BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 6424221)

  • 1. [Hemodilution and plasmapheresis in the therapy of hyperviscosity syndromes].
    Di Lollo F; Fazzini G; Avanzi G
    Ric Clin Lab; 1983; 13 Suppl 3():225-44. PubMed ID: 6424221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Classification and physiopathology of the hyperviscosity syndrome].
    Larcan A; Stoltz JF
    Journ Annu Diabetol Hotel Dieu; 1983; ():179-97. PubMed ID: 6358611
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood hyperviscosity syndromes. Classification and physiopathological understanding. Therapeutic deductions].
    Larcan A; Stoltz JF
    Ann Med Interne (Paris); 1983; 134(5):395-410. PubMed ID: 6360007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of blood hyperviscosity].
    Larcan A; Stoltz JF
    Bull Acad Natl Med; 1982 Mar; 166(3):375-82. PubMed ID: 6751484
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
    Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
    Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis and hyperviscosity syndrome].
    Corral Alonso M; Barbolla ML
    Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasmapheresis therapy of hyperviscosity syndromes].
    Kamanabroo D
    Internist (Berl); 1983 Jan; 24(1):39-42. PubMed ID: 6341280
    [No Abstract]   [Full Text] [Related]  

  • 9. Syndromes of hyperviscosity.
    Wells R
    N Engl J Med; 1970 Jul; 283(4):183-6. PubMed ID: 4987394
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperviscosity syndrome in Waldenström's macroglobulinemia.
    Krol TC; Wood WS
    Am Fam Physician; 1981 Aug; 24(2):187-9. PubMed ID: 6789661
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
    Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
    Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
    Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
    Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based focused review of management of hyperviscosity syndrome.
    Stone MJ; Bogen SA
    Blood; 2012 Mar; 119(10):2205-8. PubMed ID: 22147890
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemostatic therapy in a patient with acquired von Willebrand disease and Waldenström disease with plasmapheresis and DDAVP].
    Thies K; Budde U; Hellstern P
    Beitr Infusionsther; 1990; 26():179-82. PubMed ID: 1703824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperviscosity in plasma cell dyscrasias.
    Kwaan HC
    Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmapheresis and cold sensitivity of immunoglobulin molecules. II. A study of macroglobulinemia polyclonalis spuria and immune complex disease.
    Waldenström JG
    Acta Med Scand; 1984; 216(5):467-74. PubMed ID: 6240922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of hyperviscosity by apheresis.
    Zarkovic M; Kwaan HC
    Semin Thromb Hemost; 2003 Oct; 29(5):535-42. PubMed ID: 14631553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperviscosity retinopathy. A scientific approach to therapy.
    Grindle CF; Buskard NA; Newman DL
    Trans Ophthalmol Soc U K (1962); 1976 Jul; 96(2):216-9. PubMed ID: 827830
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic plasmapheresis--a new form of adjuvant treatment (author's transl)].
    Tilz GP; Teubl I; Kopplhuber C; Vollmann H; Lanzer G
    Med Klin; 1976 Nov; 71(45):1952-7. PubMed ID: 825711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.